Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions.
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
